CELLECT BIOTECH/S (NASDAQ:APOP)‘s stock had its “buy” rating reiterated by HC Wainwright in a research report issued on Tuesday. They presently have a $14.00 price target on the stock. HC Wainwright’s target price suggests a potential upside of 91.00% from the stock’s previous close.
The analysts wrote, “We continue to expect that this cushion should be sufficient to fund operations through 2019. The January 2018 financing included unregistered warrants with an exercise price of $12.00 per ADS, which could if exercised in full accrue an additional $3.2M to the company. Assuming Cellect remains capital- efficient and warrant exercises proceed as projected, we believe the company could continue to operate well into 2020 without requiring further capital to be raised. R&D expenses were slightly below our projection at $0.8M vs. $1M, while G&A spending was somewhat above our estimate at roughly $1M vs. $0.9M. The company recorded a net loss of only $0.16 per share vs. our projection of $0.30 per share, primarily due to the favorable impact of about $0.8M in financial non- cash items.””
Best Heal Care Stocks To Own For 2019: Washington Real Estate Investment Trust(WRE)
Advisors' Opinion:- [By Max Byerly]
Colony Group LLC cut its stake in shares of Washington Real Estate Investment Trust (NYSE:WRE) by 8.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 26,266 shares of the real estate investment trust’s stock after selling 2,410 shares during the period. Colony Group LLC’s holdings in Washington Real Estate Investment Trust were worth $797,000 as of its most recent SEC filing.
- [By Dan Caplinger]
The stock market lost ground on Monday, as investors appeared to have second thoughts about the future of the U.S. economy even as trade negotiations with China appear to be going well. The Dow Jones Industrial Average had been down by more than 400 points earlier in the session before recovering to finish lower by just 207, and broader benchmarks saw more modest declines on a percentage basis. Even amid the carnage, there was some good news for certain companies. Washington Real Estate Investment Trust (NYSE:WRE), Ascendis Pharma (NASDAQ:ASND), and Bluegreen Vacations (NYSE:BXG) were among the top performers. Here's why they did so well.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on Washington Real Estate Investment Trust (WRE)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Shares of Washington Real Estate Investment Trust (NYSE:WRE) have been assigned an average rating of “Hold” from the nine brokerages that are covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and four have given a buy rating to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $31.33.
Best Heal Care Stocks To Own For 2019: LeMaitre Vascular, Inc.(LMAT)
Advisors' Opinion:- [By Lisa Levin]
Shares of LeMaitre Vascular, Inc. (NASDAQ: LMAT) were down 20 percent to $31.235 after the company reported weaker-than-expected Q1 results.
Essendant Inc (NASDAQ: ESND) was down, falling around 24 percent to $7.255 after reporting downbeat quarterly earnings.
- [By Lisa Levin]
Shares of LeMaitre Vascular, Inc. (NASDAQ: LMAT) were down 17 percent to $32.47 after the company reported weaker-than-expected Q1 results.
Essendant Inc (NASDAQ: ESND) was down, falling around 23 percent to $7.38 after reporting downbeat quarterly earnings.
- [By Logan Wallace]
Shares of LeMaitre Vascular Inc (NASDAQ:LMAT) have been assigned an average rating of “Hold” from the eight analysts that are presently covering the firm, Marketbeat.com reports. Six research analysts have rated the stock with a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $34.40.
- [By Brian Feroldi]
In this week's episode of Industry Focus: Healthcare, hidden-gems aficionado Brian Feroldi shares three exciting healthcare small caps that don't stick investors with a mountain of risk -- LeMaitre Vascular (NASDAQ:LMAT), HealthEquity (NASDAQ:HQY), and NovoCure (NASDAQ:NVCR). What do these companies do? How did they carve out a niche for themselves? What does the competition look like? And, because you can't mitigate all the risk away, what risks should investors watch for? Tune in and find out more.
- [By Lisa Levin]
Shares of LeMaitre Vascular, Inc. (NASDAQ: LMAT) were down 17 percent to $32.19 after the company reported weaker-than-expected Q1 results.
LKQ Corporation (NASDAQ: LKQ) was down, falling around 16 percent to $31.49 following weaker-than-expected quarterly earnings.
Best Heal Care Stocks To Own For 2019: Trinity Industries Inc.(TRN)
Advisors' Opinion:- [By ]
5. Trinity Industries (NYSE: TRN)
This industrial company is trading lower by over 15% in 2018. A substantial shareholder named Valueact Holdings has purchased over one million shares in the $32.00 range. - [By Shane Hupp]
Trinity Industries Inc (NYSE:TRN) was up 1.1% during trading on Monday . The company traded as high as $34.53 and last traded at $34.48. Approximately 77,366 shares changed hands during trading, a decline of 96% from the average daily volume of 1,960,164 shares. The stock had previously closed at $34.10.
- [By Stephan Byrd]
Trinity Industries Inc (NYSE:TRN) – Research analysts at Seaport Global Securities reduced their Q3 2018 EPS estimates for shares of Trinity Industries in a report issued on Tuesday, October 9th. Seaport Global Securities analyst W. Milby now forecasts that the transportation company will post earnings of $0.37 per share for the quarter, down from their previous estimate of $0.40.
- [By Max Byerly]
Get a free copy of the Zacks research report on Trinity Industries (TRN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Ethan Ryder]
CIBC Private Wealth Group LLC boosted its holdings in Trinity Industries Inc (NYSE:TRN) by 668.0% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 9,300 shares of the transportation company’s stock after buying an additional 8,089 shares during the period. CIBC Private Wealth Group LLC’s holdings in Trinity Industries were worth $319,000 at the end of the most recent reporting period.
- [By Shane Hupp]
Trinity Industries (NYSE:TRN) updated its FY 2019 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $1.15-1.35 for the period, compared to the Thomson Reuters consensus estimate of $1.28.
Best Heal Care Stocks To Own For 2019: Skechers U.S.A., Inc.(SKX)
Advisors' Opinion:- [By Chris Lange]
When Skechers USA Inc. (NYSE: SKX) reported its most recent quarterly results after the markets closed on Thursday, the shoe firm said that it had $0.31 in earnings per share (EPS) and $1.08 billion in revenue. This compared with consensus estimates of $0.23 in EPS and $1.1 billion in revenue, as well as the $0.21 per share and $970.59 million posted the fourth quarter of last year.
- [By Joseph Griffin]
Get a free copy of the Zacks research report on Skechers USA (SKX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Rick Munarriz]
If you're a Skechers (NYSE:SKX) investor, no one will blame you for being nervous. The walking and casual athletic-footwear specialist reports quarterly results after the market close on Thursday, and last time, the stock got rocked.
- [By Lisa Levin]
Shares of Skechers USA Inc (NYSE: SKX) were down 27 percent to $30.62. Skechers reported in-line earnings for its first quarter, but issued weak guidance for the second quarter.
- [By Stephan Byrd]
Skechers USA Inc (NYSE:SKX) has earned a consensus rating of “Hold” from the sixteen research firms that are covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, five have given a hold rating and nine have given a buy rating to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $41.95.
Best Heal Care Stocks To Own For 2019: Columbia Sportswear Company(COLM)
Advisors' Opinion:- [By Shane Hupp]
Brasada Capital Management LP grew its stake in shares of Columbia Sportswear (NASDAQ:COLM) by 25.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,669 shares of the textile maker’s stock after purchasing an additional 1,148 shares during the quarter. Brasada Capital Management LP’s holdings in Columbia Sportswear were worth $433,000 as of its most recent SEC filing.
- [By Ethan Ryder]
Bessemer Group Inc. lowered its position in shares of Columbia Sportswear (NASDAQ:COLM) by 7.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,300 shares of the textile maker’s stock after selling 1,800 shares during the period. Bessemer Group Inc.’s holdings in Columbia Sportswear were worth $1,791,000 as of its most recent SEC filing.
- [By Shane Hupp]
Columbia Sportswear (NASDAQ:COLM) had its target price raised by research analysts at Wedbush from $102.00 to $103.00 in a research report issued on Wednesday. The firm presently has an “outperform” rating on the textile maker’s stock. Wedbush’s price target would indicate a potential upside of 13.99% from the company’s current price.
Best Heal Care Stocks To Own For 2019: Schnitzer Steel Industries, Inc.(SCHN)
Advisors' Opinion:- [By Ethan Ryder]
Royce & Associates LP lessened its position in Schnitzer Steel Industries, Inc. (NASDAQ:SCHN) by 1.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 292,391 shares of the basic materials company’s stock after selling 4,400 shares during the quarter. Royce & Associates LP’s holdings in Schnitzer Steel Industries were worth $9,854,000 at the end of the most recent quarter.
- [By Logan Wallace]
Los Angeles Capital Management & Equity Research Inc. lifted its position in shares of Schnitzer Steel Industries, Inc. (NASDAQ:SCHN) by 149.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 60,730 shares of the basic materials company’s stock after buying an additional 36,390 shares during the quarter. Los Angeles Capital Management & Equity Research Inc. owned about 0.23% of Schnitzer Steel Industries worth $2,047,000 at the end of the most recent reporting period.
- [By Motley Fool Staff]
Schnitzer Steel Industries (NASDAQ:SCHN) Q3 2018 Earnings Conference CallJun. 26, 2018 11:30 a.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
No comments:
Post a Comment